Mahdi Gharaibeh

Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer

Sibylle Loibl, Delphine Loirat, Sara M. Tolaney et al. · European Journal of Cancer · 2022 · 45 citations · Full text

Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States

Ahmed Aljabri, Yvonne Huckleberry, Jason H. Karnes et al. · Blood · 2016 · 44 citations · Full text

Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer

Mahdi Gharaibeh, Ali McBride, J. Lyle Bootman et al. · Journal of Medical Economics · 2016 · 37 citations

Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators

Jeroen P. Jansen, Devin Incerti, Alex Mutebi et al. · Journal of Medical Economics · 2017 · 24 citations · Full text

Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry

Philip J. Mease, Scott Stryker, Mei Liu et al. · Arthritis Research & Therapy · 2021 · 23 citations · Full text